Vantage Consulting Group’s Royalty Pharma RPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-57,500	Closed	-$1.56M	–	216
2023 Q3	$1.56M	Sell	57,500 -593,190	-91%	-$17.6M	1.05%	6
2023 Q2	$20M	Sell	650,690 -371,504	-36%	-$12.6M	11.51%	2
2023 Q1	$36.8M	Hold	1,022,194	–	–	20.91%	2
2022 Q4	$35.5M	Hold	1,022,194	–	–	20.94%	2
2022 Q3	$41.1M	Sell	1,022,194 -29,701	-3%	-$1.27M	24%	2
2022 Q2	$44.2M	Sell	1,051,895 -1,675,959	-61%	-$68.7M	24.8%	2
2022 Q1	$106M	Sell	2,727,854 -1,873,298	-41%	-$73.6M	41.47%	1
2021 Q4	$183M	Sell	4,601,152 -3,261,390	-41%	-$127M	49.3%	1
2021 Q3	$284M	Sell	7,862,542 -1,439,903	-15%	-$56M	60.85%	1
2021 Q2	$381M	Buy	9,302,445 +596,894	+7%	+$25.4M	66.33%	1
2021 Q1	$380M	Sell	8,705,551 -12,771,731	-59%	-$606M	76.23%	1
2020 Q4	$1.07B	Buy	+21,477,282	New	+$911M	87.53%	1